About David

David is co-chair of Cooley’s global capital markets practice group. David practices general business and corporate law, representing both emerging and public companies in a variety of matters – including capital markets transactions, Securities and Exchange Commission (SEC) reporting and compliance, and corporate governance matters. He routinely represents issuers and investment banks in complex securities offerings – including initial public offerings (IPOs), follow-on offerings, 144A offerings, private investments in public equity (PIPEs), deSPACs and direct listings. His practice also includes company formations, venture capital financings and general corporate matters.

View full bio

Passions

IPOs

Literature

Gator football

Experience

Uber Announces $1 Billion Exchangeable Senior Notes Offering

Uber Announces $1 Billion Exchangeable Senior Notes Offering

May 15, 2025

Cooley advised Uber Technologies (NYSE: UBER), a technology platform that uses a massive network, top technology, operational excellence and deep product knowledge to power movement from Point A to Point B, on its offering of $1 billion principal amount of 0% exchangeable senior notes due 2028.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Timothy Nguyen
Special Counsel, San Francisco
Matt Kong
Associate, San Francisco
Carlos Ramirez
Partner, San Diego
Eric Blanchard
Partner, Boston
Siana Lowrey
Of Counsel
David Peinsipp
Partner, San Francisco
Jacob B. Hanna
Associate, San Francisco
Talya Kornitzer
Associate, New York
Eileen Marshall
Partner, Washington, DC
Timothy Shapiro
Partner, Palo Alto
Darren DeStefano
Partner, Reston
Shannon Eagan
Partner in Charge – Palo Alto, Palo Alto
Claire Keast-Butler
Co-Partner in Charge – London, London
Michael Neumeister
Partner, Los Angeles
Ellie Seber
Partner, Santa Monica

Related Practices & Industries

Debt Finance
Capital Markets
Tax
Technology
Securities Litigation + Enforcement
Business Restructuring

Cooley Advises RegCell on Transition to Being US-Based Company While Securing up to $45.8M of Funding

Cooley Advises RegCell on Transition to Being US-Based Company While Securing up to $45.8M of Funding

March 18, 2025

Cooley represented Japanese-founded RegCell in its transition to being a US-based company in connection with the closing of $45.8 million of funding, consisting of $8.5 million in seed financing – co-led by The University of Tokyo Edge Capital Partners and Fast Track Initiative – and up to $37.3 million in nondilutive funding from Japan’s Agency for Medical Research and Development. Lawyers Dave Peinsipp, Sale Kwon and Yichen Liu led the Cooley team advising RegCell, a developer of cell therapies intended to treat autoimmune diseases and cancer.

Related contacts

David Peinsipp
Partner, San Francisco
Sale Kwon
Partner, Palo Alto
Yichen Liu
Associate, Palo Alto

Related Practices & Industries

Emerging Companies
Venture Capital
Life Sciences

Alumis Announces Merger With ACELYRIN

Alumis Announces Merger With ACELYRIN

February 6, 2025

Cooley advised Alumis (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, on its definitive agreement with ACELYRIN to merge in an all-stock transaction.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Polina A. Demina
Special Counsel, New York
Sangitha Palaniappa
Associate, Palo Alto
Christine Turner
Associate, Colorado
Shaun (Tianjie) Wang
Associate, New York
Megan Browdie
Partner, Washington, DC
Lauren Creel
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Sarah Lightdale
Partner, New York
Phil Mitchell
Partner, New York
Jeremy Morrison
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jennifer Raab
Partner, Palo Alto
Patrick Van Eecke
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Caroline Vu
Special Counsel, Palo Alto
Christopher Andrews
Associate, New York
Dannielle Antone
Associate, San Francisco
Tamara Chin Loy
Associate, Washington, DC
Navya Dasari
Associate, New York
Joshua Elefant
Associate, Palo Alto
Winda Fung
Associate, Santa Monica
Gary Warren Hunt III
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Kristina Krasnikova
Associate, Palo Alto
Sunny J. Levine
Associate, Colorado
Amanda Lindner
Associate, New York
Jayne M. Munger
Associate, New York
Julianne Orr
Associate, San Francisco
Michael Pelle
Associate, New York
Breanna Qin
Associate, Palo Alto
Bartholomäus Regenhardt
Associate, Brussels
Jesse Schulman
Associate, Colorado
Freddy Yip
Associate, Hong Kong
Isabella Ysebrands
Associate, San Francisco

Related Practices & Industries

Mergers and Acquisitions
Life Sciences

Septerna Announces Upsized $331.2 Million IPO

Septerna Announces Upsized $331.2 Million IPO

November 1, 2024

Cooley advised the underwriters of Septerna, a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery, on its upsized $331.2 million initial public offering.

Read more

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Grady Chang
Associate, Santa Monica
Megan Drill
Associate, San Diego
Allison Kutner
Associate, New York
Sarah Miller
Associate, New York
Marjorie O'Neill
Associate, San Francisco
Minkyu Park
Special Counsel, New York
Dr. Mark Westwood
Associate, Palo Alto
Hardy Zhou
Associate, New York

Related Practices & Industries

Capital Markets
Healthcare
Life Sciences
Life Sciences and Healthcare Regulatory
Patent Counseling and Prosecution
Compensation and Benefits
Cyber/Data/Privacy
CFIUS
Tax

Upstream Bio Announces Upsized $293 Million IPO

Upstream Bio Announces Upsized $293 Million IPO

October 15, 2024

Cooley advised the underwriters of Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, on its upsized $293 million initial public offering.

Read more

Related contacts

Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Senior Counsel, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Megan Drill
Associate, San Diego
Zack Gong
Associate, Shanghai
Peter A. Haddad
Associate, San Diego
David D. Kim
Associate, San Francisco
Jessica Koffel
Special Counsel, Brussels
Sarah Miller
Associate, New York
Lawrence Traylor
Associate, Santa Monica

Related Practices & Industries

Capital Markets
Healthcare
Life Sciences
Life Sciences and Healthcare Regulatory
Patent Counseling and Prosecution
Cyber/Data/Privacy
Compensation and Benefits
Tax
CFIUS
View more

David always has creative solutions for the more complex and bespoke issues. He has a reputation for being the go-to for answers to the hardest questions.

Chambers USA, 2024

David is the only partner I would use for an IPO or financing, he is that good.

Chambers USA, 2025

Admissions and credentials

California

Not admitted to practice in Florida

Rankings and accolades

Chambers USA: Band 1: Capital Markets: Debt & Equity: Western United States – Nationwide (2019 – 2025)

Chambers USA: Band 1: Capital Markets: Debt & Equity – California (2019 – 2025)

Chambers USA: SPACs – Nationwide (2023)

The Legal 500 US: Leading Lawyer in Capital Markets: Equity Offerings (2020 – 2023)

Daily Journal: California Lawyer Attorneys of the Year Awards (2020)

IFLR1000 US: Lawyer of the Year – Capital Markets (2020)

Daily Journal: Top 100 Lawyers in California (2019 – 2020)

Law 360: Capital Markets MVP (2019)

The Legal 500 US: Next Generation Lawyer in Capital Markets: Equity (2019)

Daily Journal: Top 20 Under 40 (2014)

Memberships and affiliations

American Bar Association (ABA)

The Bar Association of San Francisco

Representative issuers:

Dave has represented companies/investment banks on capital market transactions involving issuers across industries, such as: 10X Genomics, 4D Molecular Therapeutics, Accelerate Diagnostics, Acutus Medical, Aerohive Networks, Alteryx, ALX Oncology, Ambarella, Amyris, Applied Molecular Transport, Anthera Pharmaceuticals, Apigee, Applied Molecular Transport, Annexon, Apptio, Arcadia Biosciences, Arcutis Biotherapeutics, Aridis Pharmaceuticals, ARMO BioSciences, Ascendis Pharma, ASLAN Pharmaceuticals, Atlassian, Athira Pharma, Audentes Therapeutics, Cision, Crinetics Pharmaceuticals, Dermira, DocuSign, Doximity, Dutch Bros., EHang, Eidos Therapeutics, Expensify, Fantex, FIGS, FireEye, Five Prime Therapeutics, Global Blood Therapeutics, Gossamer Bio, Graphite Bio, Gritstone Oncology, Guardant Health, Health Catalyst, HealthEquity, Hyperion Therapeutics, IGM Biosciences, Ignyta, Immune Design, Inhibrx, Invitae, Kinnate Biopharma, Kodiak Sciences, LinkedIn, Livongo Health, Lulu’s Fashion Lounge, Lyell Immunopharma, MINDBODY, Mobile Iron, NantKwest, Nanthealth, NerdWallet, New Relic, Olema Pharmaceuticals, Ooma, Opendoor Labs, Otonomy, Pliant Therapeutics, Principia Biopharma, PROCEPT BioRobotics, ProNai, ProQR Therapeutics, PROS Holdings, Rigel Pharmaceuticals, Qualtrics, Root, Sana Biotechnology, Satsuma Pharmaceuticals, Savara, Shockwave Medical, Sierra Oncology, Smart Share Global, Snap, Stitch Fix, Sutro Biopharma, Sweetgreen, Syndax Pharmaceuticals, Tableau Software, Taiwan Liposome Company, Treace Medical Concepts, Tricida, Trivascular, Twilio, Uber, Ventyx, ViewRay, Warby Parker, Wish, Xenon Pharmaceuticals, Xometry, Yelp, Zendesk, Zscaler, Zymeworks, Zynga.